{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:30:23Z","timestamp":1791261023898,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and internal organs. Protein tyrosine phosphatases have received little attention in the study of SSc or fibrosis. Here, we show that the tyrosine phosphatase PTP4A1 is highly expressed in fibroblasts from patients with SSc. PTP4A1 and its close homolog PTP4A2 are critical promoters of TGF\u03b2 signaling in primary dermal fibroblasts and of bleomycin-induced fibrosis in vivo. PTP4A1 promotes TGF\u03b2 signaling in human fibroblasts through enhancement of ERK activity, which stimulates SMAD3 expression and nuclear translocation. Upstream from ERK, we show that PTP4A1 directly interacts with SRC and inhibits SRC basal activation independently of its phosphatase activity. Unexpectedly, PTP4A2 minimally interacts with SRC and does not promote the SRC\u2013ERK\u2013SMAD3 pathway. Thus, in addition to defining PTP4A1 as a molecule of interest for TGF\u03b2-dependent fibrosis, our study provides information regarding the functional specificity of different members of the PTP4A subclass of phosphatases.<\/jats:p>","DOI":"10.1038\/s41467-017-01168-1","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T14:57:18Z","timestamp":1508165838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["PTP4A1 promotes TGF\u03b2 signaling and fibrosis in systemic sclerosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Cristiano","family":"Sacchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Santelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Piera-Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Chernitskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Kiosses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ceponis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus H.","family":"Kaestner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Boin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Bottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"1168_CR1","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheumatol. 65, 2737\u20132747 (2013).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8, 42\u201354 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1168_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/BOR.0b013e3283524b9a","volume":"24","author":"C Beyer","year":"2012","unstructured":"Beyer, C., Distler, O. & Distler, J. H. Innovative antifibrotic therapies in systemic sclerosis. Curr. Opin. Rheumatol. 24, 274\u2013280 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1168_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0b013e32833038ce","volume":"21","author":"M Trojanowska","year":"2009","unstructured":"Trojanowska, M. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr. Opin. Rheumatol. 21, 623\u2013629 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1168_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis, R. Transforming growth factor beta\u2014at the centre of systemic sclerosis. Nat. Rev. Rheumatol. 10, 706\u2013719 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1168_CR6","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI77958","volume":"125","author":"LM Rice","year":"2015","unstructured":"Rice, L. M. et al. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J. Clin. Invest. 125, 2795\u20132807 (2015).","journal-title":"J. Clin. Invest."},{"key":"1168_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-010-0142-x","volume":"13","author":"N Iwamoto","year":"2011","unstructured":"Iwamoto, N., Distler, J. H. & Distler, O. Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials. Curr. Rheumatol. Rep. 13, 21\u201327 (2011).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1168_CR8","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071\u20132082 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1168_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/annrheumdis-2014-207109","volume":"75:","author":"J Huang","year":"2015","unstructured":"Huang, J. et al. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis. Ann. Rheum. Dis. 75:, 883\u2013890 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1168_CR10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/art.27463","volume":"62","author":"S Bu","year":"2010","unstructured":"Bu, S. et al. Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis Rheumatol. 62, 2117\u20132126 (2010).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR11","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/art.34336","volume":"64","author":"PS Tsou","year":"2012","unstructured":"Tsou, P. S. et al. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis Rheumatol. 64, 1978\u20131989 (2012).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR12","doi-asserted-by":"publisher","first-page":"34152","DOI":"10.1074\/jbc.M113.546077","volume":"289","author":"S Li","year":"2014","unstructured":"Li, S. et al. SHP2 positively regulates TGFbeta1-induced epithelial-mesenchymal transition modulated by its novel interacting protein Hook1. J. Biol. Chem. 289, 34152\u201334160 (2014).","journal-title":"J. Biol. Chem."},{"key":"1168_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ajpath.2014.01.016","volume":"184","author":"Y Aschner","year":"2014","unstructured":"Aschner, Y. et al. Protein tyrosine phosphatase alpha mediates profibrotic signaling in lung fibroblasts through TGF-beta responsiveness. Am. J. Pathol. 184, 1489\u20131502 (2014).","journal-title":"Am. J. Pathol."},{"key":"1168_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso, A. et al. Protein tyrosine phosphatases in the human genome. Cell 117, 699\u2013711 (2004).","journal-title":"Cell"},{"key":"1168_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1742-4658.2012.08565.x","volume":"280","author":"P Rios","year":"2013","unstructured":"Rios, P., Li, X. & Kohn, M. Molecular mechanisms of the PRL phosphatases. FEBS J. 280, 505\u2013524 (2013).","journal-title":"FEBS J."},{"key":"1168_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-008-9121-3","volume":"27","author":"DC Bessette","year":"2008","unstructured":"Bessette, D. C., Qiu, D. & Pallen, C. J. PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev. 27, 231\u2013252 (2008).","journal-title":"Cancer Metastasis Rev."},{"key":"1168_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14728222.2014.892926","volume":"18","author":"AM Campbell","year":"2014","unstructured":"Campbell, A. M. & Zhang, Z. Y. Phosphatase of regenerating liver: a novel target for cancer therapy. Expert Opin. Ther. Targ. 18, 555\u2013569 (2014).","journal-title":"Expert Opin. Ther. Targ."},{"key":"1168_CR18","doi-asserted-by":"publisher","first-page":"42316","DOI":"10.1074\/jbc.M111.286302","volume":"286","author":"Y Bai","year":"2011","unstructured":"Bai, Y. et al. PRL-1 protein promotes ERK1\/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein. J. Biol. Chem. 286, 42316\u201342324 (2011).","journal-title":"J. Biol. Chem."},{"key":"1168_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/onc.2014.33","volume":"34","author":"S Hardy","year":"2015","unstructured":"Hardy, S. et al. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis. Oncogene 34, 986\u2013995 (2015).","journal-title":"Oncogene"},{"key":"1168_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1074\/jbc.M116.759944","volume":"292","author":"P Gimenez-Mascarell","year":"2017","unstructured":"Gimenez-Mascarell, P. et al. Structural basis of the oncogenic interaction of phosphatase PRL-1 with the magnesium transporter CNNM2. J. Biol. Chem. 292, 786\u2013801 (2017).","journal-title":"J. Biol. Chem."},{"key":"1168_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/nat.2013.0454","volume":"24","author":"P Jarver","year":"2014","unstructured":"Jarver, P., O\u2019Donovan, L. & Gait, M. J. A chemical view of oligonucleotides for exon skipping and related drug applications. Nucleic Acid Ther. 24, 37\u201347 (2014).","journal-title":"Nucleic Acid Ther."},{"key":"1168_CR22","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2174\/1381612811319160010","volume":"19","author":"HM Moulton","year":"2013","unstructured":"Moulton, H. M. In vivo delivery of morpholino oligos by cell-penetrating peptides. Curr. Pharm. Des. 19, 2963\u20132969 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"1168_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/bioinformatics\/bts366","volume":"28","author":"AC Zambon","year":"2012","unstructured":"Zambon, A. C. et al. GO-elite: a flexible solution for pathway and ontology over-representation. Bioinformatics 28, 2209\u20132210 (2012).","journal-title":"Bioinformatics"},{"key":"1168_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1168_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck, R. & Zhang, Y. E. SMAD-dependent and SMAD-independent pathways in TGF-beta family signalling. Nature 425, 577\u2013584 (2003).","journal-title":"Nature"},{"key":"1168_CR26","doi-asserted-by":"publisher","first-page":"32172","DOI":"10.1074\/jbc.M112.393462","volume":"287","author":"Y Dong","year":"2012","unstructured":"Dong, Y. et al. Phosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and activating Akt protein. J. Biol. Chem. 287, 32172\u201332179 (2012).","journal-title":"J. Biol. Chem."},{"key":"1168_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0659-5","volume":"17","author":"N Ruzehaji","year":"2015","unstructured":"Ruzehaji, N. et al. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis. Arthritis Res. Ther. 17, 145 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"1168_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.cellsig.2006.11.008","volume":"19","author":"KR Ross","year":"2007","unstructured":"Ross, K. R., Corey, D. A., Dunn, J. M. & Kelley, T. J. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal. 19, 923\u2013931 (2007).","journal-title":"Cell Signal."},{"key":"1168_CR29","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1016\/j.yexcr.2013.07.013","volume":"319","author":"JA Browne","year":"2013","unstructured":"Browne, J. A., Liu, X., Schnaper, H. W. & Hayashida, T. Serine-204 in the linker region of SMAD3 mediates the collagen-I response to TGF-beta in a cell phenotype-specific manner. Exp. Cell Res. 319, 2928\u20132937 (2013).","journal-title":"Exp. Cell Res."},{"key":"1168_CR30","doi-asserted-by":"publisher","first-page":"29043","DOI":"10.1074\/jbc.M703537200","volume":"282","author":"JP Sun","year":"2007","unstructured":"Sun, J. P. et al. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration. J. Biol. Chem. 282, 29043\u201329051 (2007).","journal-title":"J. Biol. Chem."},{"key":"1168_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","volume":"3","author":"EJ Morris","year":"2013","unstructured":"Morris, E. J. et al. Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov. 3, 742\u2013750 (2013).","journal-title":"Cancer Discov."},{"key":"1168_CR32","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","volume":"66","author":"JJ Fiordalisi","year":"2006","unstructured":"Fiordalisi, J. J., Keller, P. J. & Cox, A. D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res. 66, 3153\u20133161 (2006).","journal-title":"Cancer Res."},{"key":"1168_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/pr.114.009381","volume":"67","author":"RS Knipe","year":"2015","unstructured":"Knipe, R. S., Tager, A. M. & Liao, J. K. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol. Rev. 67, 103\u2013117 (2015).","journal-title":"Pharmacol. Rev."},{"key":"1168_CR34","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/art.23677","volume":"58","author":"A Akhmetshina","year":"2008","unstructured":"Akhmetshina, A. et al. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. Arthritis Rheumatol. 58, 2553\u20132564 (2008).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR35","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1172\/JCI76614","volume":"124","author":"Y Funato","year":"2014","unstructured":"Funato, Y. et al. Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression. J. Clin. Invest. 124, 5398\u20135410 (2014).","journal-title":"J. Clin. Invest."},{"key":"1168_CR36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J. Recept. Signal Transduct. Res. 35, 600\u2013604 (2015).","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"1168_CR37","first-page":"4245","volume":"32","author":"M Geletu","year":"2012","unstructured":"Geletu, M., Trotman-Grant, A. & Raptis, L. Mind the gap; regulation of gap junctional, intercellular communication by the SRC oncogene product and its effectors. Anticancer Res. 32, 4245\u20134250 (2012).","journal-title":"Anticancer Res."},{"key":"1168_CR38","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1021\/bi8020789","volume":"48","author":"Y Luo","year":"2009","unstructured":"Luo, Y., Liang, F. & Zhang, Z. Y. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1\/2 pathways. Biochemistry 48, 1838\u20131846 (2009).","journal-title":"Biochemistry"},{"key":"1168_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/0008-5472.CAN-06-2436","volume":"67","author":"H Achiwa","year":"2007","unstructured":"Achiwa, H. & Lazo, J. S. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Cancer Res. 67, 643\u2013650 (2007).","journal-title":"Cancer Res."},{"key":"1168_CR40","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.1073\/pnas.96.24.13738","volume":"96","author":"KF Harris","year":"1999","unstructured":"Harris, K. F. et al. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl. Acad. Sci. USA 96, 13738\u201313743 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1168_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cub.2008.12.007","volume":"19","author":"GS Laszlo","year":"2009","unstructured":"Laszlo, G. S. & Cooper, J. A. Restriction of Src activity by Cullin-5. Curr. Biol. 19, 157\u2013162 (2009).","journal-title":"Curr. Biol."},{"key":"1168_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1242\/jcs.01643","volume":"118","author":"D Tvorogov","year":"2005","unstructured":"Tvorogov, D., Wang, X. J., Zent, R. & Carpenter, G. Integrin-dependent PLC-gamma1 phosphorylation mediates fibronectin-dependent adhesion. J. Cell Sci. 118, 601\u2013610 (2005).","journal-title":"J. Cell Sci."},{"key":"1168_CR43","doi-asserted-by":"publisher","first-page":"21444","DOI":"10.1074\/jbc.M000453200","volume":"275","author":"Q Zeng","year":"2000","unstructured":"Zeng, Q. et al. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 275, 21444\u201321452 (2000).","journal-title":"J. Biol. Chem."},{"key":"1168_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00002281-200111000-00010","volume":"13","author":"CP Denton","year":"2001","unstructured":"Denton, C. P. & Abraham, D. J. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr. Opin. Rheumatol. 13, 505\u2013511 (2001).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1168_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","volume":"5","author":"J Varga","year":"2009","unstructured":"Varga, J. & Pasche, B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat. Rev. Rheumatol. 5, 200\u2013206 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1168_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1046\/j.1523-1747.1998.00073.x","volume":"110","author":"T Kawakami","year":"1998","unstructured":"Kawakami, T. et al. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J. Invest. Dermatol. 110, 47\u201351 (1998).","journal-title":"J. Invest. Dermatol."},{"key":"1168_CR47","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/art.20225","volume":"50","author":"J Pannu","year":"2004","unstructured":"Pannu, J. et al. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma. Arthritis Rheumatol. 50, 1566\u20131577 (2004).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR48","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","volume":"74","author":"N Altorok","year":"2015","unstructured":"Altorok, N., Tsou, P. S., Coit, P., Khanna, D. & Sawalha, A. H. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann. Rheum. Dis. 74, 1612\u20131620 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"1168_CR49","doi-asserted-by":"publisher","first-page":"12009","DOI":"10.1021\/bi0509191","volume":"44","author":"JP Sun","year":"2005","unstructured":"Sun, J. P. et al. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry 44, 12009\u201312021 (2005).","journal-title":"Biochemistry"},{"key":"1168_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00418-016-1427-6","volume":"149","author":"J Gungabeesoon","year":"2016","unstructured":"Gungabeesoon J., Tremblay M. L., Uetani N. Localizing PRL-2 expression and determining the effects of dietary Mg on expression levels. Histochem. Cell Biol. 149, 99\u2013111 (2016).","journal-title":"Histochem. Cell Biol."},{"key":"1168_CR51","doi-asserted-by":"publisher","first-page":"E2934","DOI":"10.1073\/pnas.1301985110","volume":"110","author":"V Reiterer","year":"2013","unstructured":"Reiterer, V., Fey, D., Kolch, W., Kholodenko, B. N. & Farhan, H. Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1\/2. Proc. Natl. Acad. Sci. USA 110, E2934\u2013E2943 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1168_CR52","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(94)90035-3","volume":"79","author":"M Perego","year":"1994","unstructured":"Perego, M. et al. Multiple protein-aspartate phosphatases provide a mechanism for the integration of diverse signals in the control of development in B. subtilis. Cell 79, 1047\u20131055 (1994).","journal-title":"Cell"},{"key":"1168_CR53","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/art.23436","volume":"58","author":"C Skhirtladze","year":"2008","unstructured":"Skhirtladze, C. et al. Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Arthritis Rheumatol. 58, 1475\u20131484 (2008).","journal-title":"Arthritis Rheumatol."},{"key":"1168_CR54","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1093\/nar\/gkp544","volume":"37","author":"M Ponticos","year":"2009","unstructured":"Ponticos, M., Harvey, C., Ikeda, T., Abraham, D. & Bou-Gharios, G. JunB mediates enhancer\/promoter activity of COL1A2 following TGF-beta induction. Nucleic Acids Res. 37, 5378\u20135389 (2009).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01168-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T20:17:37Z","timestamp":1719519457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01168-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]},"assertion":[{"value":"1 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported in part by investigator-initiated grants from Kyowa Kirin Pharmaceutical Research Inc. (formerly Kyowa Hakko Kirin California Inc.) to N.B. and from Illumina Inc. to C.S. The La Jolla Institute for Allergy and Immunology holds a pending patent application, \u201cPTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis\u201d, with N.B., C.S. and S.M.S. named as inventors. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1060"}}